Cutler Group LP Pmv Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$1.51 - $3.12 $3,926 - $8,112	-2,600 Reduced 96.3%	100 $0
Q4 2023 Jan 18, 2024	SELL	$1.23 - $6.6 $1,845 - $9,900	-1,500 Reduced 35.71%	2,700 $0
Q3 2023 Nov 07, 2023	BUY	$6.01 - $8.93 $25,242 - $37,506	4,200 New	4,200 $2,000
Q3 2022 Oct 25, 2022	SELL	$11.4 - $17.18 $85,500 - $128,850	-7,500 Reduced 97.4%	200 $0
Q2 2022 Aug 04, 2022	BUY	$9.23 - $22.43 $71,071 - $172,711	7,700 New	7,700 $0
Q3 2021 Oct 26, 2021	SELL	$26.84 - $36.58 $69,784 - $95,108	-2,600 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$28.01 - $36.01 $72,826 - $93,626	2,600 New	2,600 $3,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $67.1M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.